Pharmaceuticals News
-
Egypt, Iraq Discuss Cooperation in Drug Export, Registration
Abdel Ghaffar lauded deeply-rooted relations binding Egypt with Iraq and their continued coordination in all domains.
-
Egypt’s Eva Pharma gears up to roll out veterinary vaccines from its new complex
The company has already invested EGP 980 mn on the first phase of the EGP 1.8 bn complex.
-
Health ministry issues over 300,000 treatment decisions at state expense in Ramadan
The project happened in all governorates of the republic, at a total cost of more than LE1.7 billion during the holy month of Ramadan.
-
Egyptian digital marketplace Pharmacy Marts raises 6-figure bridge round
The platform allows pharmacists to search online for the products missing in their inventory, all the way to choosing suppliers and ordering.
-
Rameda reports 37% year-over-year increase in 4Q23 revenue to EGP 534m
The company’s revenues rose by 37% year-over-year to EGP 534m in 4Q23, fueled by robust growth across all Rameda’s sectors.
-
Egypt’s Pharmacy Marts secures bridge round from Acasia Ventures
Pharmacy Marts claims to have covered 20 per cent of Egypt’s total market, and boasts over 200 suppliers on its platform.
-
Health Minister discusses means to boost cooperation to export medicine, medical cosmetics to Africa
Spokesman for the Health Ministry said that the minister urged the members of the EFIA to form a workgroup with some African countries.
-
GlaxoSmithKline Egypt concluded 2023 with significant sales leap, exceeding two billion pounds
he company's financial performance for 2023 reflected strong results, with sales reaching 2.24 billion Egyptian pounds, a 23% increase.
-
Egypt begins immediate release of food commodities and medicines
At the same time, the government decision to exempt about 12 goods from duties for a period of six months expires on April 10.
-
Egypt’s Health Ministry discusses cooperation with AstraZeneca
The meeting reviewed the previous cooperation projects, especially the partnership between the ministry, AstraZeneca, Philips, and the London School.
-
Kahira Pharmaceuticals’, Egypt profits climb 140.7% in 6 months
Kahira Pharmaceuticals is an Egypt-based company involved in the manufacture and trade of pharmaceutical products for human and veterinary use.
-
Rameda expands its exports to Vietnam, Sudan, and Kuwait
Rameda, a leading Egyptian pharmaceutical company, has signed several partnership agreements with various agents in different countries.
-
Top 20 pharmaceutical manufacturers in Egypt
With investments, innovation, and a focus on both traditional and alternative medicine, Egypt is poised to maintain its leadership in pharmaceuticals.
-
Why Egyptians are struggling to find their medicines?
Despite the country’s strategic reserve of pharmaceuticals, some Egyptians, especially those with chronic diseases, are still struggling.
-
Egypt's medicine stock covers local demand for 6-12 months: Official
Egypt's strategic stock of medicines is enough to cater to domestic consumption for a period of 6 to 12 months.
-
EIB, AfDB support launch of African Pharmaceutical Technology Foundation
Africa advanced efforts to develop an independent drug industry after Rwanda agreed to host the African Pharmaceutical Technology Foundation (APTF) .
-
APEX Pharma to build EGP 4 bln in factories in Egypt, Saudi Arabia next year
Elba added that the plan involves constructing a new factory in Egypt with an initial investment of over EGP 1 billion.
-
Valu and GSK Launch First-of-its-Kind Partnership in the Egyptian Pharmaceutical Industry
Valu and GSK aim to create a more inclusive and equitable healthcare ecosystem, aligning with their shared vision of advancing public health.
-
Saudi Batterjee Group announces acquisition plans in Egypt’s pharmaceutical market
The Saudi Batterjee Holding Group has unveiled its plans to acquire a pharmaceutical company listed on the Egyptian Exchange (EGX) within 6 months.
-
Egypt: Ibn Sina Pharma to invest over $6mln in 2024
The company’s earnings before interest, taxes, and depreciation (EBITDA) increased by 101% during the first nine months of 2023.